MOLECULAR MECHANISMS OF THE PATHOGENESIS OF POSTMENOPAUSAL ENDOMETRIAL POLYPS


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Despite the high prevalence and proven malignization potential of endometrial polys, their etiology and pathogenesis are not yet clear. With the advance of molecular medicine, an investigation of the underlying mechanisms in the development of postmenopausal endometrial polyps may elucidate their pathogenesis. Russian and foreign studies of the molecular aspects of the pathogenesis of postmenopausal endometrial polyps are overviewed.

全文:

受限制的访问

作者简介

SH. SATTAROV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: docshuhrat@yahoo.com
Moscow

E. KOGAN

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: koganevg@gmail.com
Moscow

S. SARKISOV

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: 7341497@mail.ru
Moscow

I. MAMIKONYAN

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: irulikjan@rambler.ru
Moscow

M. BOIKO

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: bma555@bk.ru
Moscow

S. GYURDZHYAN

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia

Email: medicjan@yandex.ru
Moscow

参考

  1. Ткаченко Э.Р, Адамян Л.В. Современные подходы к хирургическому лечению внутриматочной патологии. В кн.: Современные технологии в диагностике и лечении гинекологических заболеваний: ХХ юбилейный Международный конгресс с курсом эндоскопии. М.; 2007: 335-6.
  2. Хужокова И.Н, Саркисов С.Э, Уланкина О.Г, Кучукова М.Ю. Диагностика и лечение полипов эндометрия. Вопросы гинекологии, акушерства и перинатологии. 2009; 8(1): 102-6.
  3. Бреусенко В.Г., Голова Ю.А, Каппушева Л.М., Мишиева О.И, Кирикова Ю.М., Цечоева ТС. Современные подходы в лечении пролиферативных процессов эндометрия в постменопаузе. В кн.: Прилепская В.Н., ред. Клиническая гинекология. М.: МЕДпресс-информ; 2007: 315-23.
  4. Хитрых О.В. Отдаленные результаты и оптимизация тактики лечения полипов эндометрия в постменопаузе: Автореф. дис.. канд. мед. наук. М.; 2009.
  5. Уланкина О.Г., Хужокова И.Н., Азиева А.А. Особенности гинекологической патологии у пациенток старшей возрастной группы. В кн.: Материалы V Российского форума «Мать и дитя». М.; 2003: 600.
  6. Hassa H, Tekin B, Senses T., Kaya M., Karatas A. Are the site, diameter, and number of endometrial polyps related with symptomatology? Am. J. Obstet. Gynecol. 2006; 194(3): 718-21.
  7. American Association of Gynecologic Laparoscopists. AAGL practice report: practice guidelines for the diagnosis and management of endometrial polyps. J. Minim. Invasive Gynecol. 2012; 19(1): 3-10.
  8. Costa-Paiva L, Godoy C.E. Jr., Antunes A.Jr, Caseiro J.D, Arthuso M, Pinto-Neto A.M. Risk of malignancy in endometrial polyps in premenopausal and postmenopausal women according to clinicopathologic characteristics. Menopause. 2011; 18(12): 1278-82.
  9. Sant’Ana de Almeida E.C., Nogueira A.A., Candido dos Reis F.J., Zambelli Ramalho L.N., Zucoloto S. Immunohistochemical expression of estrogen and progesterone receptors in endometrial polyps and adjacent endometrium in postmenopausal women. Maturitas. 2004; 49(3): 229-33.
  10. Savelli L, De Iaco P., Santini D, Rosati F, Ghi T., Pignotti E. et al. Histopathologic features and risk factors for benignity, hyperplasia and cancer in endometrial polyps. Am. J. Obstet. Gynecol. 2003; 188: 927-31.
  11. Shushan A., Revel A., Rojansky N. How often are endometrial polyps malignant? Gynecol. Obstet. Invest. 2004; 58(4): 212-5.
  12. Baiocchi G., Manci N., Pazzaglia M., Giannone L., Burnelli L., Giannone E. et al. Malignancy in endometrial polyps: a 12-year experience. Am. J. Obstet. Gynecol. 2009; 201: 462-4.
  13. Хужокова И.Н. Диагностическая и лечебная тактика при полипах эндометрия в постменопаузе: Автореф. дис. канд. мед. наук. М.; 2001.
  14. Сметник В.П., Тумилович Л.Г. Неоперативная гинекология: Руководство для врачей. 3-е изд. М.: МИА; 2005. 632 с.
  15. Fletcher J.A., Pinkus J.L., Lage J.M., Morton C.C., Pinkus G.S. Clonal 6p21 rearrangement is restricted to the mesenchymal component of an endometrial polyp. Genes Chromosomes Cancer. 1992; 5(3): 260-3.
  16. Houghton O., McCluggage W.G. The expression and diagnostic utility of p63 in the female genital tract. Adv. Anat. Pathol. 2009; 16(5): 316-21.
  17. Nogueira A.A., Sant’Ana de Almeida E.C., Poli Neto O.B., Zambelli Ramalho L.N. Immunohistochemical expression of p63 in endometrial polyps: evidence that a basal cell immunophenotype is maintained. Menopause. 2006; 13(5): 826-30.
  18. Buckley C.H., Fox H. Biopsy pathology of the endometrium. 2nd ed. London: Arnold; 2002.
  19. Biron-Shental T., Tepper R., Fishman A., Shapira J., Cohen I. Recurrent endometrial polyps in postmenopausal breast cancer patients on tamoxifen. Gynecol. Oncol. 2003; 90(2): 382-6.
  20. Cohen I. Endometrial polyps in pre-and postmenopausal women: factors associated with malignancy. Maturitas. 2008; 59(1): 99-100.
  21. Van den Bosch T., Van Schoubroeck D., Ameye L., De Brabanter J., Van Huffel S., Timmerman D. Ultrasound assessment of endometrial thickness and endometrial polyps in women on hormonal replacement therapy. Am. J. Obstet. Gynecol. 2003; 188: 1249-53.
  22. Bakour S.H., Gupta J.K., Khan K.S. Risk factors associated with endometrial polyps in abnormal uterine bleeding. Int. J. Obstet. Gynecol. 2002; 76: 165-8.
  23. Perrone G., DeAngelis C., Critelli C., Capri O., Galoppi P., Santoro G. et al. Hysteroscopic findings in postmenopausal abnormal uterine bleeding: a comparison between HRT users and non-users. Maturitas. 2002; 43(4): 251-5.
  24. Taylor L.J., Jackson T.L., Reid J.G., Duffy S.R. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps. Br. J. Obstet. Gynaecol. 2003; 110: 794-8.
  25. Erdemoglu E., Guney M., Karahan N., Mungan T. Expression of cyclooxygenase-2, matrix metalloproteinase-2 and matrix metalloproteinase-9 in premenopausal and postmenopausal endometrial polyps. Maturitas. 2008; 59(3): 268-74.
  26. Bergeron C. Effect of estrogens and antiestrogens on the endometrium. Gynecol. Obstet. Fertil. 2002; 30(12): 933-7.
  27. Thijs I., Neven P., Van Hooff I., Tonglet R., Van Belle Y., De Muylder X., Vanderick G. Oestrogen and progesterone receptor expression in postmenopausal endometrial polyps and their surrounding endometrium. Eur. J. Cancer. 2000; 36(Suppl.4): 93-118.
  28. Belisario M.S., Vassallo J., Andrade L.A., Alvarenga M., Pinto G.A., Monteiro I.M. The expression of the hormone receptors in the endometrium and endometrial polyps in postmenopausal women and its relationship to body mass index. Maturitas. 2006; 53(1): 114-8.
  29. McTiernan A., Tworoger S.S., Ulrich C.M., Yasui Y., Irwin M.L., Rajan K.B. et al. Effect of exercise on serum estrogen in postmenopausal women: a 12-month randomized clinical trial. Cancer Res. 2004; 64(8): 2923-8.
  30. Reslova T., Tosner J., Resl M., Kugler R., Vavrova I. Endometrial polyps. A clinical study of 245 cases. Arch. Gynecol. Obstet. 1999; 262: 133-9.
  31. Рымашевский А.Н., Воробьев С.В., Андрющенко Ю.А. Гормональные и метаболические особенности у женщин с полипами эндометрия и ожирением в постменопаузе. Фундаментальные исследования. 2011; 9(ч.3): 496-500.
  32. Arnold J.T., Kaufman D.G., Seppala M., Lessey B.A. Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model. Hum. Reprod. 2001; 16(5): 836-45.
  33. Maia H.Jr., Maltez A., Athayde C., Coutinho E.M. c-erbB2 over-expression in endometrial hyperplasia induced by estrogens. Maturitas. 2002; 43(1): 41-7.
  34. Vinatier D., Dufour P., Subtil D. Apoptosis: a programmed cell death involved in ovarian and uterine physiology. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996; 67: 85-102.
  35. Zheng W., Feng Y.J., Gandhi M., Siu S., Hom E., Caputo T., Lauchlan S.C. Persistent expression of bcl-2 onco-protein in endometrial carcinoma correlates with hormone receptor positivity. Int. J. Gynecol. Cancer. 1996; 6: 235-40.
  36. Maia H.Jr., Maltez A., Studart E., Athayde C., Coutinho E.M. Ki-67, Bcl-2 and p53 expression in endometrial polyps and in the normal endometrium during the menstrual cycle. Br. J. Obstet. Gynaecol. 2004; 111(11): 1242-7.
  37. Risberg B., Karlsson K., Abeler V., Lagrelius A., Davidson B., Karlsson M. Dissociated expression of Bcl-2 and Ki67 in endometrial lesions: diagnostic and histogenetic implications. Int. J. Gynecol. Pathol. 2002; 21: 155-60.
  38. McGurgan P., Taylor L.J., Duffy S.R., O’Donovan P.J. Are endometrial polyps from pre-menopausal women similar to post-menopausal women? An immunohistochemical comparison of endometrial polyps from pre-and post-menopausal women. Maturitas. 2006; 54(3): 277-84.
  39. Morsi H.M., Leers M.P., Jager W., Bjorklund V., Radespiel-Troger M., el Kabarity H. et al. The patterns of expression of an apoptosis-related CK 18 neoepitope, the Bcl-2 protooncogene, and the ki67 proliferation marker in normal, hyperplastic and malignant endometrium. Int. J. Gynecol. Pathol. 2000; 19(2): 118-26.
  40. Otsuki Y., Misaki O., Sugimoto O., Ito Y., Tsujimoto Y., Akao Y. Cyclic Bcl-2 expression in human uterine endometrium during menstrual cycle. Lancet. 1994; 344: 28-9.
  41. AntunesA.Jr.,AndradeL.A., PintoG.A., LeaoR.,Pinto-NetoA.M., Costa-Paiva L. Is the immunohistochemical expression of proliferation (Ki-67) and apoptosis (Bcl-2) markers and cyclooxigenase-2 (COX-2) related to carcinogenesis in postmenopausal endometrial polyps? Anal. Quant. Cytol. Histol. 2012; 34(5): 264-72.
  42. Hileeto D., Fadare O., Martel M., Zheng W. Age dependent association of endometrial polyps with increased risk of cancer involvement. World J. Surg. Oncol. 2005; 3: 8.
  43. Dal Cin P., De Wolf F., Klerckx P., Van Den Berghe H. The 6p21chromosome region is nonrandomly involved in endometrial polyps. Gynecol. Oncol. 1992; 46: 393-6.
  44. Giordano G., Gnetti L., Merisio C., Melpignano M. Postmenopausal status, hypertension and obesity as risk factors for malignant transformation in endometrial polyps. Maturitas. 2007; 56(2): 190-7.
  45. Schlesinger C., Silverberg S.G. Tamoxifen-associated polyps (basalomas) arising in multiple endometriotic foci: a case report and review of the literature. Gynecol. Oncol. 1999; 73(2): 305-11.
  46. McCluggage W.G., Sumathi V.P., McManus D.T. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy. Hum. Pathol. 2003; 34(9): 939-43.
  47. Ben-Arie A., Goldchmit C., Laviv Y., Levy R., Caspi B., Huszar M. et al. The malignant potential of endometrial polyps. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004; 115(2): 206-10.
  48. Mbatsogo B.A., Le Bouёdec G., Michy T., Bourdel N., Fouilloux G., Dauplat J. Endometrial cancers arising in polyps associated with tamoxifen use. Gynecol. Obstet. Fertil. 2005; 33(12): 975-9.
  49. Farrell R., Scurry J., Otton G., Hacker N.F. Clinicopathologic review of malignant polyps in stage 1A carcinoma of the endometrium. Gynecol. Oncol. 2005; 98(2): 254-62.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2013
##common.cookie##